‘We hear you, Sunkist Fruit Gems fans!’ the company wrote, saying it had found a new manufacturer for the kosher synagogue staple

Phase I results show early promise for a vaccine designed to prevent pancreatic cancer in people at high risk of developing the disease.

YouTube video by sdwolfpup

The updated formula for Spikevax is now approved for individuals 6 months through 64 years of age with at least one underlying condition placing them at high risk for severe outcomes from COVID-19, and all adults 65 years of age and older. mNEXSPIKE, Moderna's latest COVID-19 vaccine, is approved for individuals 12 through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19, and all adults 65 years of age and older.